BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18583466)

  • 1. Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization.
    Vettor R; Granzotto M; De Stefani D; Trevellin E; Rossato M; Farina MG; Milan G; Pilon C; Nigro A; Federspil G; Vigneri R; Vitiello L; Rizzuto R; Baratta R; Frittitta L
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3541-50. PubMed ID: 18583466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40.
    Schnell S; Schaefer M; Schöfl C
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):173-80. PubMed ID: 17101212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
    Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C
    Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single Amino Acid Mutation (R104P) in the E/DRY Motif of GPR40 Impairs Receptor Function.
    Guo S; Zhang J; Zhang S; Li J
    PLoS One; 2015; 10(10):e0141303. PubMed ID: 26505901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone.
    Wu P; Yang L; Shen X
    Biochem Biophys Res Commun; 2010 Dec; 403(1):36-9. PubMed ID: 21036144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linoleic acid activates GPR40/FFA1 and phospholipase C to increase [Ca2+]i release and insulin secretion in islet beta-cells.
    Zhou YJ; Song YL; Zhou H; Li Y
    Chin Med Sci J; 2012 Mar; 27(1):18-23. PubMed ID: 22734209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release.
    Fujiwara K; Maekawa F; Yada T
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E670-7. PubMed ID: 15914509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice.
    Tan CP; Feng Y; Zhou YP; Eiermann GJ; Petrov A; Zhou C; Lin S; Salituro G; Meinke P; Mosley R; Akiyama TE; Einstein M; Kumar S; Berger JP; Mills SG; Thornberry NA; Yang L; Howard AD
    Diabetes; 2008 Aug; 57(8):2211-9. PubMed ID: 18477808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding.
    Kebede M; Alquier T; Latour MG; Semache M; Tremblay C; Poitout V
    Diabetes; 2008 Sep; 57(9):2432-7. PubMed ID: 18559658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
    Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S
    Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR40 gene Arg211His polymorphism may contribute to the variation of insulin secretory capacity in Japanese men.
    Ogawa T; Hirose H; Miyashita K; Saito I; Saruta T
    Metabolism; 2005 Mar; 54(3):296-9. PubMed ID: 15736105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat.
    Doshi LS; Brahma MK; Sayyed SG; Dixit AV; Chandak PG; Pamidiboina V; Motiwala HF; Sharma SD; Nemmani KV
    Metabolism; 2009 Mar; 58(3):333-43. PubMed ID: 19217448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.
    Steneberg P; Rubins N; Bartoov-Shifman R; Walker MD; Edlund H
    Cell Metab; 2005 Apr; 1(4):245-58. PubMed ID: 16054069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets.
    Alquier T; Peyot ML; Latour MG; Kebede M; Sorensen CM; Gesta S; Ronald Kahn C; Smith RD; Jetton TL; Metz TO; Prentki M; Poitout V
    Diabetes; 2009 Nov; 58(11):2607-15. PubMed ID: 19720802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.
    Nagasumi K; Esaki R; Iwachidow K; Yasuhara Y; Ogi K; Tanaka H; Nakata M; Yano T; Shimakawa K; Taketomi S; Takeuchi K; Odaka H; Kaisho Y
    Diabetes; 2009 May; 58(5):1067-76. PubMed ID: 19401434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion.
    Tomita T; Masuzaki H; Iwakura H; Fujikura J; Noguchi M; Tanaka T; Ebihara K; Kawamura J; Komoto I; Kawaguchi Y; Fujimoto K; Doi R; Shimada Y; Hosoda K; Imamura M; Nakao K
    Diabetologia; 2006 May; 49(5):962-8. PubMed ID: 16525841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
    Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
    Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of Pollen Typhae total flavone against the palmitic acid-induced impairment of glucose-stimulated insulin secretion involving GPR40 signaling in INS-1 cells.
    Feng XT; Duan HM; Li SL
    Int J Mol Med; 2017 Sep; 40(3):922-930. PubMed ID: 28731171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR40 full agonism exerts feeding suppression and weight loss through afferent vagal nerve.
    Ueno H; Ito R; Abe SI; Ogino H; Maruyama M; Miyashita H; Miyamoto Y; Moritoh Y; Tsujihata Y; Takeuchi K; Nishigaki N
    PLoS One; 2019; 14(9):e0222653. PubMed ID: 31525244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.